---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-22-002217"
form_type: "8-K"
ticker: "ENTXW"
cik: "0001638097"
company_name: "Entera Bio Ltd."
filed_at: "2022-05-27T23:59:59+00:00"
generated_at: "2026-06-25T06:20:44.124648+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Entera Bio amends ATM sales agreement with B. Riley Securities to reflect loss of foreign private issuer status

## Summary
- Entered into Amended and Restated At Market Issuance Sales Agreement with B. Riley Securities dated May 27, 2022.
- Amendment made to reflect that Entera Bio is no longer a foreign private issuer.
- All material terms of the original agreement remain unchanged.
- Agreement allows for at-the-market offerings of ordinary shares under a Form S-3 registration statement.

## SEC filing metadata
- accession: 0001178913-22-002217
- form_type: 8-K
- ticker: ENTXW
- cik: 0001638097
- company_name: Entera Bio Ltd.
- filed_at: 2022-05-27T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638097/000117891322002217/0001178913-22-002217-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638097/000117891322002217/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-22-002217
- JSON: https://secwatch.observer/filing/0001178913-22-002217.json
- Plain text: https://secwatch.observer/filing/0001178913-22-002217.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.